Anti-CD163
| Product ID: | DB 045 |
Category: | IHC-P
|
| Documents: | Datasheet |
- A. Geirsson et al (2012) Circulation 126, S189-97
- X.Z. Ye et al (2012) J Immunol 189, 444-53
- V.L. Gadd et al (2013) Liver Int 33, 569-79
- M. Weber et al (2015) Br J Cancer 113, 510-9
- F. Wehrhan et al (2014) BMC Cancer, 14:522
- J. Park, E.B. Lee, Y.W. Song (2014) Scand J Rheumatol 43, 403-8
- M. Weber et al (2014) J Craniomaxillofac Surg 42, 1087-94
- J. Drouin-Ouellet et al (2015) Ann Neurol 78, 160-77
- F. Cicchetti et al (2014) Ann Neurol 76, 31-42
- Z.K. O'Brown et al (2015) PLoS Genet 11
- A.K. Azad et al (2015) J Immunol 195, 2019-29
- M.C. Herwig et al (2013) Exp Eye Res 107, 52-8
- R. Kridel et al (2015) Clin Cancer Res 15, 3428-35
- M. Trbusic et al (2012) J Neurol 3, 448-56
- M. Svajdler et al (2014) Am J Dermatopathol 8, 669-72
- M. Vered et al (2013) Clin Oral Investig 5, 1365-73
- M.C. Herwig et al (2015) Curr Eye Res 6, 604-10
- G. Huang et al (2014) Am J Transplant 14, 1061-72
- X. Zhang et al (2016) BMC Complementary and Alternative Medicine 16, 299
- A. Kahn et al (2017) J Oral Maxillofac Surg, 30 003-4
| DB 045-0.1 |
100 μl |
|
|
| DB 045-0.2 |
200 μl |
|
|
| DB 045-0.5 |
500 μl |
|
|
| DB 045-1 |
1 ml |
|
|
| DB 045-RTU-7 |
7 ml |
ready to use |
|
| DB 045-RTU-15 |
15 ml |
ready to use |
|
K20-T
20mM Tris-HCl, pH 8.0
20mg/ml BSA
Q86VB7
0.05% NaN
3
Human
Peptide derived from N-terminal sequence of human CD163
IHC-P, dilution 1:100 - 1:200
